Novel chloroacetamido compound CWR-J02 is an anti-inflammatory glutaredoxin-1 inhibitor

Glutaredoxin (Grx1) is a ubiquitously expressed thiol-disulfide oxidoreductase that specifically catalyzes reduction of S-glutathionylated substrates. Grx1 is known to be a key regulator of pro-inflammatory signaling, and Grx1 silencing inhibits inflammation in inflammatory disease models. Therefore...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Gorelenkova Miller, Olga, Cole, Kyle S., Emerson, Corey C., Allimuthu, Dharmaraja, Golczak, Marcin, Stewart, Phoebe L., Weerapana, Eranthie, Adams, Drew J., Mieyal, John J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5695812/
https://ncbi.nlm.nih.gov/pubmed/29155853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0187991
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia